Liver Allograft Failure After Nivolumab Treatment—A Case Report With Systematic Literature Research

BACKGROUND: Orthotopic liver transplantation (OLT) is a potential curative treatment in patients with hepatocellular carcinoma (HCC); however, treatment options for recurrent HCC after OLT are limited. Immune checkpoint inhibitors, such as nivolumab, an inhibitor of programmed cell death protein 1,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gassmann, Dimitri, Weiler, Stefan, Mertens, Joachim C., Reiner, Cäcilia S., Vrugt, Bart, Nägeli, Mirjam, Mangana, Joanna, Müllhaupt, Beat, Jenni, Fabienne, Misselwitz, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Liver Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092180/
https://www.ncbi.nlm.nih.gov/pubmed/30255136
http://dx.doi.org/10.1097/TXD.0000000000000814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092180/
https://www.ncbi.nlm.nih.gov/pubmed/30255136
http://dx.doi.org/10.1097/TXD.0000000000000814

Ejemplares similares